A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends ...

Key Takeaways Psoriasis makes skin cells grow too fast, forming thick, scaly patchesGenes plus triggers like stress, ...

Psoriasis reacts differently for each person. You could find that particular behaviors or situations cause your psoriasis to flare, even for something that’s not well recognized as a trigger.

Psoriasis, a skin condition, can put your vision at risk — here’s what to do to help protect your eyesight and keep seeing clearly.

Melvin Lee, MD; Robert E. Kalb, MD Disclosures Dermatology Nursing. 2008;20 (2):105-111.

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat generalised pustular psoriasis (GPP) flares.

The association between dupilumab and psoriasis was further supported by validation in patients with asthma without atopic dermatitis (HR 2.13, 95% CI 1.38-3.31), the authors noted.

Psoriasis and Psoriatic Arthritis Alliance (PAPAA), 01923 672837 Psoriasis Association, 01604 251 620 You can also get support from your local Healthwatch. NICE is not responsible for the quality or ...

Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults. Last reviewed: 18 June 2025 Next review: This guidance will be reviewed if there is ...

The UK’s National Institute for Health and Care Excellence (NICE) has today recommended Spevigo (spesolimab) for the treatment of generalized pustular psoriasis (GPP) flares in adults in England and ...